Study comparing pain and early recovery in patients undergoing kidney transplant surgery using robotic surgery versus open surgery

Randomized Controlled Trial Comparing Postoperative Pain And Early Outcomes After Robotic-Assisted Versus Open Renal Transplantation - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/107095

Enrollment

Registered

2026-03-30

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N185- Chronic kidney disease, stage 5 Health Condition 2: N186- End stage renal disease

Interventions

Intervention1: Robotic-assisted kidney transplantation (RAKT): A minimally invasive procedure performed through a Pfannenstiel incision and laparoscopic ports. The kidney is placed intraperitoneally,

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed ESRD and eligible for living-donor renal transplantation

Exclusion criteria

Exclusion criteria: Cadaveric or ABO-incompatible transplant. Significant iliac vascular calcification or abnormal anatomy requiring open exposure. Multiple vessels, left iliac fossa transplant Vascular and ureteric anomalies of donor kidney Prior major pelvic surgery precluding robotic access. BMI more than 40 kilogram per meter cube (if robotic limitation). Severe cardiopulmonary disease prohibiting pneumoperitoneum

Design outcomes

Primary

Measure	Time frame
To compare postoperative pain (Numeric Rating Scale, NRS) at different intervals between patients undergoing robotic-assisted kidney transplantation (RAKT) and open renal transplantation (ORT).Timepoint: 6, 12, 24, and 48 hours, and postoperative day 3 and 7	—

Secondary

Measure	Time frame
To assess health-related quality of life (HRQOL) using KDQOL-36 and EQ-5D- 5L.Timepoint: At baseline, and 1, 3, and 6 months.;To compare analgesic consumption (opioid and non-opioid).Timepoint: ;To evaluate length of hospital stay.Timepoint: ;Cost effectiveness by QALYTimepoint: At 1, 3 and 6 months;To assess postoperative complications (wound-related, bleeding, seroma,anastomotic leak, rejection, and acute tubular necrosis).Timepoint: ;To compare graft function (serum creatinine).Timepoint: at discharge and 30 days;Warm ischemia time (WIT 1 and WIT 2) and cold ischemia timeTimepoint: Intraoperatively	—

Measure

Time frame

To assess health-related quality of life (HRQOL) using KDQOL-36 and EQ-5D- 5L.Timepoint: At baseline, and 1, 3, and 6 months.;To compare analgesic consumption (opioid and non-opioid).Timepoint: ;To evaluate length of hospital stay.Timepoint: ;Cost effectiveness by QALYTimepoint: At 1, 3 and 6 months;To assess postoperative complications (wound-related, bleeding, seroma,anastomotic leak, rejection, and acute tubular necrosis).Timepoint: ;To compare graft function (serum creatinine).Timepoint: at discharge and 30 days;Warm ischemia time (WIT 1 and WIT 2) and cold ischemia timeTimepoint: Intraoperatively

—

Countries

India

Contacts

Public ContactDr Yathin K

AIIMS, New Delhi

arunanand093@gmail.com8860759615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026